These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16706977)

  • 1. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
    Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
    J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
    Radtke KP; Griffin JH; Riceberg J; Gale AJ
    J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa.
    Gale AJ; Pellequer JL
    J Thromb Haemost; 2003 Sep; 1(9):1966-71. PubMed ID: 12941038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.
    Pipe SW; Kaufman RJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11851-6. PubMed ID: 9342326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
    Wakabayashi H; Monaghan M; Fay PJ
    J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
    Monaghan M; Wakabayashi H; Griffiths AE; Fay PJ
    J Thromb Haemost; 2016 May; 14(5):1021-30. PubMed ID: 26878264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.
    Griffiths AE; Rydkin I; Fay PJ
    J Biol Chem; 2013 May; 288(21):15057-64. PubMed ID: 23580639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
    Bloem E; Meems H; van den Biggelaar M; Mertens K; Meijer AB
    J Biol Chem; 2013 Sep; 288(36):26105-26111. PubMed ID: 23884417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
    Saenko EL; Shima M; Gilbert GE; Scandella D
    J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of thrombin-activated human factor VIII.
    Curtis JE; Helgerson SL; Parker ET; Lollar P
    J Biol Chem; 1994 Feb; 269(8):6246-51. PubMed ID: 8119969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
    Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
    J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.
    Wakabayashi H; Wintermute JM; Fay PJ
    Thromb Haemost; 2014 Jul; 112(1):43-52. PubMed ID: 24599523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
    Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
    Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.